Catherine P. Fernandez
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Brief psychodynamic-interpersonal therapy for adults with a history of self-harm: the SafePIT RCT.
Journal: Health technology assessment (Winchester, England)
Published: November 29, 2025
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.
Journal: Health technology assessment (Winchester, England)
Published: October 14, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiences.
Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: May 22, 2024
Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS).
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 07, 2023
Effectiveness of GRACE risk score in patients admitted to hospital with non-ST elevation acute coronary syndrome (UKGRIS): parallel group cluster randomised controlled trial.
Journal: BMJ (Clinical research ed.)
Published: June 14, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: June 03, 2023
Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial.
Journal: BMJ open
Published: February 24, 2022
Last Updated: 09/26/2026